235 related articles for article (PubMed ID: 25448777)
1. Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist, WIN 55,212-2.
Payandemehr B; Ebrahimi A; Gholizadeh R; Rahimian R; Varastehmoradi B; Gooshe M; Aghaei HN; Mousavizadeh K; Dehpour AR
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():140-5. PubMed ID: 25448777
[TBL] [Abstract][Full Text] [Related]
2. Effects of WIN 55,212-2 mesylate (a synthetic cannabinoid) on the protective action of clonazepam, ethosuximide, phenobarbital and valproate against pentylenetetrazole-induced clonic seizures in mice.
Luszczki JJ; Andres-Mach M; Barcicka-Klosowska B; Florek-Luszczki M; Haratym-Maj A; Czuczwar SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1870-6. PubMed ID: 21777642
[TBL] [Abstract][Full Text] [Related]
3. Effects of WIN 55,212-2 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice.
Florek-Luszczki M; Wlaz A; Zagaja M; Andres-Mach M; Kondrat-Wrobel MW; Luszczki JJ
Pharmacol Biochem Behav; 2015 Mar; 130():53-8. PubMed ID: 25592741
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2'-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
Citraro R; Russo E; Leo A; Russo R; Avagliano C; Navarra M; Calignano A; De Sarro G
Eur J Pharmacol; 2016 Nov; 791():523-534. PubMed ID: 27663280
[TBL] [Abstract][Full Text] [Related]
5. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of PPAR-gamma receptor and nitric oxide pathway in the anticonvulsant effect of acute pioglitazone on pentylenetetrazole-induced seizures in mice.
Adabi Mohazab R; Javadi-Paydar M; Delfan B; Dehpour AR
Epilepsy Res; 2012 Aug; 101(1-2):28-35. PubMed ID: 22436324
[TBL] [Abstract][Full Text] [Related]
7. Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice.
Gholizadeh S; Shafaroodi H; Ghasemi M; Bahremand A; Sharifzadeh M; Dehpour AR
Neuropharmacology; 2007 Nov; 53(6):763-70. PubMed ID: 17870135
[TBL] [Abstract][Full Text] [Related]
8. The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice.
Shafaroodi H; Samini M; Moezi L; Homayoun H; Sadeghipour H; Tavakoli S; Hajrasouliha AR; Dehpour AR
Neuropharmacology; 2004 Sep; 47(3):390-400. PubMed ID: 15275828
[TBL] [Abstract][Full Text] [Related]
9. Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist.
Bilir KA; Anli G; Ozkan E; Gunduz O; Ulugol A
Clin Exp Dermatol; 2018 Jul; 43(5):553-558. PubMed ID: 29424035
[TBL] [Abstract][Full Text] [Related]
10. Effects of WIN 55,212-2 mesylate on the anticonvulsant action of lamotrigine, oxcarbazepine, pregabalin and topiramate against maximal electroshock-induced seizures in mice.
Luszczki JJ; Wlaz A; Karwan S; Florek-Luszczki M; Czuczwar SJ
Eur J Pharmacol; 2013 Nov; 720(1-3):247-54. PubMed ID: 24161913
[TBL] [Abstract][Full Text] [Related]
11. The role of α₂-adrenoceptors in the anti-convulsant effects of cannabinoids on pentylenetetrazole-induced seizure threshold in mice.
Shafaroodi H; Moezi L; Bahremand A; Dehpour AR
Eur J Pharmacol; 2013 Aug; 714(1-3):1-6. PubMed ID: 23756131
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
13. Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB(1) agonist ACEA in the pentylenetetrazole-induced seizure in mice.
Bahremand A; Nasrabady SE; Shafaroodi H; Ghasemi M; Dehpour AR
Epilepsy Res; 2009 Apr; 84(2-3):110-9. PubMed ID: 19223154
[TBL] [Abstract][Full Text] [Related]
14. The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways.
Fukuda H; Abe T; Yoshihara S
Int Arch Allergy Immunol; 2010; 152(3):295-300. PubMed ID: 20150748
[TBL] [Abstract][Full Text] [Related]
15. Modulation of anticonvulsant effects of cannabinoid compounds by GABA-A receptor agonist in acute pentylenetetrazole model of seizure in rat.
Naderi N; Ahmad-Molaei L; Aziz Ahari F; Motamedi F
Neurochem Res; 2011 Aug; 36(8):1520-5. PubMed ID: 21516342
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects.
Wallace MJ; Wiley JL; Martin BR; DeLorenzo RJ
Eur J Pharmacol; 2001 Sep; 428(1):51-7. PubMed ID: 11779037
[TBL] [Abstract][Full Text] [Related]
17. The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice.
Bahremand A; Shafaroodi H; Ghasemi M; Nasrabady SE; Gholizadeh S; Dehpour AR
Epilepsy Res; 2008 Sep; 81(1):44-51. PubMed ID: 18502613
[TBL] [Abstract][Full Text] [Related]
18. L-type calcium channel mediates anticonvulsant effect of cannabinoids in acute and chronic murine models of seizure.
Naderi N; Ahmad-Molaei L; Mazar-Atabaki A; Ronaghi A; Shirazi-zand Z; Motiei-Langroudi SM; Eslahkar S
Neurochem Res; 2012 Feb; 37(2):279-87. PubMed ID: 21928146
[TBL] [Abstract][Full Text] [Related]
19. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.
Abalo R; Cabezos PA; Vera G; Fernández-Pujol R; Martín MI
Neurogastroenterol Motil; 2010 Jun; 22(6):694-e206. PubMed ID: 20132133
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats.
Huizenga MN; Wicker E; Beck VC; Forcelli PA
Epilepsia; 2017 Sep; 58(9):1593-1602. PubMed ID: 28691158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
